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ABSTRACT 
 
MNB/DYRK1A is a member of the Dual-specificity tyrosine-regulated kinase (DYRK) family 
that has been strongly conserved across evolution. There is considerable data implicating 
MNB/DYRK1A in brain development and adult brain function, as well as in neurodegeneration 
and Down syndrome pathologies. In this article we review our current understanding of the 
neurodevelopmental activity of MNB/DYRK1A. We discuss how MNB/DYRK1A fulfills 
several sequential roles in neuronal development and the molecular mechanisms possibly 
underlying these functions. We also summarize the evidence behind the hypotheses to explain 
how the imbalance in MNB/DYRK1A gene dosage might be implicated in the 
neurodevelopmental alterations associated with Down syndrome. Finally, we highlight some 
research directions that may help to clarify the mechanisms and functions of MNB/DYRK1A 
signaling in the developing brain.  
INTRODUCTION 
 
MNB/DYRK1A$ is a protein kinase that belongs to the Dual-specificity tyrosine-regulated 
kinase (DYRK) family. MNB/DYRK1A is highly conserved from insects to humans (Galcerán 
et al, 2003) and it displays characteristic properties that are discussed in detail in one of the three 
minireviews in this series (Becker and Sippl, 2010).  
 
The evidence from diverse experimental systems has shown various possible functions of 
MNB/DYRK1A in CNS development including its influence on proliferation, neurogenesis, 
neuronal differentiation, cell death and synaptic plasticity (see Table 1). These data, together 
with the localization of the human MNB/DYRK1A gene on chromosome 21 (Guimera et al, 1996; 
Song et al, 1996) and its overexpression in the brain of fetuses with Down syndrome (DS, 
Trisomy 21) (Guimera et al, 1999), have provided support to several hypotheses implicating 
MNB/DYRK1A in neurodevelopmental alterations underlying the cognitive deficits of DS 
(previously reviewed by Hämmerle et al, 2003a and by Dierssen & Martinez de Lagran, 2006). 
These facts have certainly stimulated and conditioned the research into the neurobiological 
functions of MNB/DYRK1A. More recently, the observation that MNB/DYRK1A is 
overexpressed in the adult DS brain (Dowjat et al, 2007), along with biochemical data, also 
implicated MNB/DYRK1A in various neurodegenerative processes. This issue is extensively 
covered by Wegiel, Gong and Hwang in the second accompanying paper of this minireview 
series.  
 
In this review we will focus on the neurodevelopmental functions of MNB/DYRK1A. We will 
discuss the data revealing the main roles interpreted by MNB/DYRK1A during brain 
development and their possible molecular mechanisms. Additionally, and given the extensive 
repertoire of putative substrates and proteins with which the MNB/DYRK1A kinase may 
interact, we will try to highlight the genes/proteins related to its neurodevelopmental activities. 
We will also discuss the possible implications of MNB/DYRK1A in the neurodevelopmental 
alterations associated with Down syndrome. Finally, we will highlight some directions for future 
research that we think may help to clarify the mechanisms and functions of MNB/DYRK1A 
signaling in the developing brain.  
 
$ Footnote: Orthologous genes have been cloned independently in various organisms and named 
Minibrain (Mnb) or Dyrk1A  
 THE DIVERSE FUNCTIONS OF MNB/DYRK1A IN NEURONAL DEVELOPMENT 
The initial evidence for the involvement of MNB/DYRK1A in neurodevelopment was provided 
by the analysis of mnb mutants of Drosophila. These flies develop a smaller adult brain, 
particularly in the optic lobes, which appears to be caused by altered proliferation in the 
neuroepithelial primordia of the larval CNS. This phenotype suggests a key function of 
MNB/DYRK1A in the regulation of neural proliferation and neurogenesis (Tejedor et al, 1995). 
The highly conserved structure of this kinase (Galceran et al, 2003) prompted extensive studies 
to be carried out on its vertebrate homologues. Indeed, a smaller brain with fewer neurons in 
certain regions was described in haploinsufficient Dyrk1A +/- mice (Fotaki et al, 2002), strongly 
suggesting an evolutionary conserved function of MNB/DYRK1A in brain development. This 
idea is also supported by the fact that truncation of the human MNB/DYRK1A gene causes 
microcephaly (Moeller et al, 2008).  
 
Although in mammals, Mnb/Dyrk1A is expressed in most adult tissues (Guimera et al, 1999, 
Okui et al, 1999), its expression seems to be prevalent during embryonic brain development and 
it gradually decreases during postnatal periods to reach low levels in the adult (Okui et al, 1999; 
Hammerle et al, 2008). Mnb⁄Dyrk1A is specifically expressed in four sequential phases during 
the development of the mouse brain: transient expression in preneurogenic progenitors; cell 
cycle-regulated expression in neurogenic progenitors; transient expression in recently born 
neurons; and persistent expression in late differentiating neurons (Hammerle et al, 2008; 
summarized in Fig. 1). This rather dynamic cellular/temporal expression strongly suggests that 
MNB/DYRK1A plays several sequential roles in neuronal development, which we shall discuss 
in this section. These roles seem to be neuron specific since the analysis of the developing 
Drosophila (Colonques, Ceron and Tejedor, unpublished results), chick (Hammerle et al, 2002; 
ibid 2003b) and mouse CNS (Hammerle et al, 2008) show that MNB/DYRK1A expression is 
restricted to neuronal lineages, although its expression in glia has also been reported in primary 
cultures (Marti et al, 2003). 
 
Proliferation and neurogenesis 
There is strong evidence that Mnb/Dyrk1A is transiently expressed during the single cell cycle of 
preneurogenic chick and mouse embryonic neuroepithelial progenitors that precedes the onset of 
neurogenesis (Hämmerle et al, 2002; Hämmerle et al, 2008). This expression is of particular 
interest since Mnb/Dyrk1A mRNA is asymmetrically segregated during cell division and it is 
inherited by only one of the daughter cells (Hämmerle et al, 2002: Fig. 1). These data, together 
with its co-expression in preneurogenic mouse neuroepithelia with Tis21 (Hammerle et al, 2002), 
an antiproliferative gene that is up-regulated in neural progenitors that make the switch from 
proliferative to neuron-generating divisions (Iacopetti et al, 1999), suggest that Mnb/Dyrk1A may 
act as a cell determinant of neurogenesis. Accordingly, Mnb/Dyrk1A could induce the switch 
from proliferative to neurogenic cell divisions in neuronal progenitors, a role for which genetic 
evidence has been obtained in Drosophila (Bieri, Colonques and Tejedor, unpublished data). 
Interestingly, the activity of Pom1p, a MNB/DYRK1A related kinase from Schizosaccharomyces 
pombe, is cell cycle regulated in relation to symmetric growth and division (Bahler and Nurse, 
2001). However, Pom1p activity is high during symmetric cell division and when lost, cells 
undergo asymmetric growth and division, the opposite to what appear to occur with 
MNB/DYRK1A in neural progenitors (Hammerle et al, 2002; Hammerle et al, 2008; Colonques 
and Tejedor, unpublished data). Moreover, mutants of mbk-1, the closest Mnb/Dyrk1A related 
gene in C. elegans, do not show neurodevelopmental alterations (Raich et al, 2003). Thus, it 
seems likely that new functions have been acquired by DYRK kinases during evolution to adapt 
to the new morphogenetic requirements of complex nervous systems.  
 
MNB⁄DYRK1A in also expressed in neurogenic progenitors in the Drosophila larval optic lobe 
(Colonques and Tejedor, unpublished data) and in the embryonic mouse brain (Hämmerle et al, 
2008). Although this expression seems to occur throughout the cell cycle, it is possible that the 
intensity of Mnb/Dyrk1A expression might vary at different cell cycle stages. Indeed, the 
expression of Mnb⁄Dyrk1A can be regulated by E2F1 (Maenz et al, 2008), a transcription factor 
that plays a key role in the control of cell proliferation. Conversely, there is also evidence that 
MNB/DYRK1A may participate in the regulation of the cell cycle. For instance, it has been 
reported that MNB/DYRK1A interacts with SNR1 in Drosophila (Kinstrie et al, 2006), a 
chromatin remodeling factor with a relevant role in cell cycle regulation (Zraly et al, 2004). 
Interestingly, increased levels of Cyclin B1 have been detected in transgenic mice 
overexpressing Mnb⁄Dyrk1A (Branchi et al, 2004) and it has recently been proposed that 
MNB/DYRK1A regulates the nuclear export and degradation of Cyclin D1 in neurogenic mouse 
neuroepithelia (Yabut et al, 2010). There are also indications that MNB/DYRK1A is involved in 
the mitosis of non-neural cell lines (Funakoshi et al, 2003). These data establish a rather complex 
scenario with MNB/DYRK1A potentially fulfilling multiple actions in cell cycle regulation for 
which we have almost no understanding of the molecular details.  
 
Interestingly, important evidence has emerged regarding the role of MNB/DYRK1A in 
terminating proliferation. Thus, based on the transient co-expression of MNB/DYRK1A with 
p27KIP1, the main cyclin-dependent kinase inhibitor in the mammalian forebrain (Nguyen et al, 
2006), we proposed that MNB/DYRK1A is involved in the developmental signals that control 
cell cycle exit and early events of neuronal differentiation (Hämmerle et al, 2008). Indeed, it was 
recently reported that the over-expression of MNB/DYRK1A in the embryonic mouse 
telencephalon inhibits proliferation and induces premature neuronal differentiation of neural 
progenitors (Yabut et al, 2010). This gain of function (GOF) was proposed to be driven through 
Cyclin D1 nuclear export and degradation. Nevertheless, it has still to be proven whether the 
effect on Cyclin D1 is a direct effect of MNB/DYRK1A or an indirect consequence of cell cycle 
withdrawal. Thus, confirmation of this mechanism by loss of function (LOF) experiments would 
be important, especially since MIRK/DYRK1B, the closest homologue of MNB/DYRK1A, 
enhances Cyclin D1 turnover (Ewton et al, 2003).  
 
Neuronal differentiation 
In terms of the possible role of MNB/DYRK1A in early stages of neuronal differentiation, a 
recent report shows that the interaction and phosphorylation of the intracellular domain of 
NOTCH by MNB/DYRK1A attenuates NOTCH signaling in transfected neural cell lines 
(Fernandez-Martinez et al, 2009). NOTCH mediated lateral inhibition is a key mechanism to 
regulate neuronal differentiation in the vertebrate CNS (reviewed by Louvi and Artavanis-
Tsakonas, 2006). During neurogenesis, the cells in which NOTCH signaling is activated remain 
as progenitors while those in which NOTCH activity diminishes differentiate into neurons. Thus, 
while the possible effects of MNB/DYRK1A kinase, as well as the underlying molecular 
mechanisms, need to be assessed in adequate models of the developing CNS, it is tempting to 
hypothesize that the MNB/DYRK1A kinase may regulate the onset of neuronal differentiation by 
inhibiting NOTCH signaling. 
 
Another rather interesting possibility is that MNB/DYRK1A influences neuronal differentiation 
through the transcriptional regulator REST/NRSF. Using genetic approaches, transchromosomic 
models of DS, embryonic stem cells with partial trisomy 21 and transgenic Mnb/Dyrk1A mice, it 
has been shown that an imbalance in Mnb/Dyrk1A dosage perturbs Rest/Nrsf levels, altering gene 
transcription programs of early embryonic development (Canzonetta et al, 2009). REST/NRSF is 
expressed strongly during early brain development in non-neuronal tissues and in neural 
progenitors, cells in which it represses fundamental neuronal genes (Chong et al, 1995). 
Furthermore, activation of REST/NRSF target genes is both necessary and sufficient for the 
transition from pluripotent embryonic stem cells to neural progenitor cells, and from these to 
mature neurons (Ballas et al, 2005). In addition, phosphorylation by MNB/DYRK1A also 
regulates the transcriptional activity of GLI1 (Mao et al, 2002), a major effector of SHH 
signaling that is a key pathway in the regulation of proliferation/differentiation during vertebrate 
CNS development (Ruiz i Altaba et al, 2002).  
 
Given the roles played by MNB/DYRK1A in sequential steps of neurogenesis and its capacity to 
interact with and/or modulate different signaling pathways (FGF, NGF, SHH, NFAT, etc), it is 
tempting to hypothesize that MNB/DYRK1A plays a key role in coordinating neural 
proliferation and neuronal differentiation. Such coordination is crucial for proper brain 
development since premature differentiation or overproliferation can alter the balance between 
neuronal populations leading to mental disorders and neuropathologies.  
 
MNB/DYRK1A has also been implicated in various aspects of late neuronal differentiation.  
Thus, MNB/DYRK1A kinase activity was upregulated in response to bFGF during the 
differentiation of immortalized hippocampal progenitor cells. Blockade of this upregulation 
inhibited neurite formation. The mechanism proposed implicates phosphorylation of the 
transcription factor CREB (Yang et al, 2001). MNB/DYRK1A overexpression also potentiates 
nerve growth factor (NGF)-mediated neuronal differentiation of PC12 cells by facilitating the 
formation of a Ras/B-Raf/MEK1 multiprotein complex in a manner independent of 
MNB/DYRK1A kinase activity (Kelly and Rahmani, 2005). Furthermore, the upregulation of 
MNB⁄DYRK1A expression and its translocation to the nucleus precedes the onset of dendrite 
formation in several differentiating neuronal populations (Hammerle et al, 2003b; Hammerle et 
al, 2008; see also Fig. 1). Indeed, the number of neurites developed by new born mouse 
hippocampal pyramidal neurons in culture is diminished when MNB/DYRK1A kinase activity is 
inhibited  (Goeckler et al, 2009), indicating that MNB/DYRK1A kinase activity is required for 
neurite formation. So far, the mechanisms underlying this role of MNB/DYRK1A remain 
unclear. In addition, we observed that MNB/DYRK1A concentrates on the apical side of 
dendrites in differentiating neurons (Hammerle et al, 2003b; Hammerle et al, 2008), suggesting a 
possible role in dendrite growth. The fact that cortical pyramidal cells from haploinsuffcient 
Dyrk1A+/- mice were considerably smaller and less branched than those of control littermates 
further supports this idea (Benavides-Piccione et al, 2005). 
Although the mechanisms underlying the effects of MNB/DYRK1A in dendritogenesis remain 
unknown, several possibilities might be considered in future studies. First, a kinome RNAi 
screen implicated MNB/DYRK1A in the regulation of actin-based protrusions in CNS-derived 
Drosophila cell lines (Liu et al, 2009). Thus, MNB/DYRK1A could be involved in regulating 
actin dynamics, an important process in the regulation of neuronal morphology. Second, it has 
been shown that MNB/DYRK1A primes specific sites of MAP1B for GSK3β phosphorylation, 
an event that seems to be associated with alterations in microtubule stability (Scales et al, 2009). 
It has also been sown that Drosophila MNB interacts with SNR1 (Kinstrie et al, 2006), a 
member of the SWI/SNF complex, which is involved in the morphogenesis of dendritic arbors in 
Drosophila sensory neurons (Parrish et al, 2006). Moreover, MNB/DYRK1A interacts with INI1 
(the SNR1 mammalian orthologue) in transfected neural cell lines (Lepagnol-Bestel et al, 2009). 
In addition, the MNB/DYRK1A kinase has been shown to be a negative regulator of NFAT 
signaling (Arron et al, 2006; Gwack et al, 2006), which plays an important role in axonal growth 
during vertebrate development (Graef et al, 2003). Finally, it is worth mentioning that two 
known substrates of the MNB/DYRK1A kinase co-localize with MNB/DYRK1A on the apical 
side of growing dendrites in several groups of neurons (Hammerle et al, 2003b; Hammerle et al, 
2008; Sitz et al, 2008): Dynamin 1 (Chen-Hwang et al, 2002; Huang et al, 2004), an important 
element in membrane trafficking; and SEPT4 (Sitz et al, 2008), a cytoskeletal scaffolding 
component implicated in neurodegeneration (Kinoshita et al, 1998).  
 
There are also some indications that MNB/DYRK1A might be involved in synaptic funtions. At 
the molecular level, it has been shown that MNB/DYRK1A binds to, phosphorylates and/or 
modulates the interaction of several components of the endocytic protein complex machinery 
such as Amphiphysin, Dynamin1, Endophilin 1 and Synaptojanin 1 (Chen-Hwang et al, 2002; 
Huang et al, 2004; Adayev et al, 2006; Murakami et al, 2006; Murakami et al, 2009), suggesting 
that it is involved in synaptic vesicle recycling. Transgenic mice overexpressing Mnb/Dyrk1A 
exhibit altered synaptic plasticity associated to learning and memory defects (Ahn et al, 2006), 
while haploinsufficient Dyrk1A +/- mice have reduced number of spines in the dendrites of 
cortical pyramidal cells (Benavides-Piccione et al. 2005) and show alterations in the pre- and 
postsynaptic components of dopaminergic transmission (Martinez de Lagran et al, 2007). Thus, 
although these phenotypes may be due to changes in synaptic plasticity related to 
MNB/DYRK1A function in the adult brain, we should not rule out that these phenotypes might 
reflect impaired synapse formation during development, particularly since dendritogenesis and 
synaptogenesis are two processes that are tightly co-ordinated during brain development (Cline, 
2001).  
 
Finally, we must stress that although MNB/DYRK1A is widely expressed in the developing 
CNS, there are clear indications that MNB/DYRK1A does not affect neuronal 
proliferation/differentiation in all CNS structures. For instance, regional morphological 
phenotypes have been reported in the brain of Mnb/Dyrk1A mutant flies (Tejedor et al, 1995) and 
mice (Fotaki et al, 2002). Furthermore, the effect of Mnb/Dyrk1A LOF and GOF in the 
developing mouse retina indicates that the main role of MNB/DYRK1A in this tissue may be 
related to cell death/survival rather than to cell proliferation/differentiation (Laguna et al, 2008).  
 
 
POSSIBLE IMPLICATIONS OF MNB/DYRK1A IN THE NEURODEVELOPMENTAL 
ALTERATIONS ASSOCIATED WITH DOWN SYNDROME. 
The human MNB/DYRK1A orthologue was initially localized in the so called DS Critical Region 
(DSCR) (Guimerá et al., 1996; Song et al, 1996), the minimal region of Chromosome 21 that 
when triplicated confers most DS phenotypes (Delabar et al, 1993). This finding together with its 
overexpression in fetuses with DS (Guimera et al., 1999) initially suggested the implication of 
MNB/DYRK1A in a broad range of DS phenotypes. However, a recent more refined genetic 
analysis of numerous HSA21 segmental trisomies has generated a high-resolution genetic map of 
DS phenotypes (Korbel et al, 2009). According to this study, there is not a single DSCR but 
rather different ones for the diverse phenotypic features. Thus, the extra dosage of 
MNB/DYRK1A appears to be associated to a more restricted repertoire of DS phenotypes than 
previously thought, including mental retardation but excluding congenital heart disease. 
 
The brains of individuals with DS are characterized by their reduced size and a decrease in 
neuronal density in certain regions (reviewed by Coyle et al, 1986). This neuronal deficit most 
probably originates through alterations in neurogenesis during development since it is already 
detected in fetuses and children with DS (Wisniewski et al, 1984; Schmidt-Sidor et al, 1990). 
Accordingly, altered neural proliferation and neurogenesis have been found in the forebrain of 
fetuses with DS and in trisomic DS mouse models (Chakrabarti et al, 2007; Contestabile et al, 
2007; Guidi et al, 2008). 
 
Based on the previously described functions of MNB/DYRK1A in the transition from 
proliferation to differentiation during neurogenesis, we predict that overexpression of 
MNB/DYRK1A in the developing brain of fetuses with DS could contribute to this neuronal 
deficit in several ways. Firstly, through its role as an asymmetric determinant of neurogenesis, 
the overexpression of MNB/DYRK1A may cause the precocious onset of neurogenesis in 
progenitors and the concomitant depletion of the proliferating progenitor pool (Fig. 2). Secondly, 
due to its role in regulating the cell cycle exit of neurons, the overexpression of MNB/DYRK1A 
may induce premature cell cycle arrest of neurogenic progenitors leading to a decrease in the 
number of neurons generated by each progenitor. Thus, the combined effects of impairing these 
two activities could result in a decrease in the production of neurons (Fig. 2). Considering the 
effect of MNB/DYRK1A on cell cycle regulators like Cyclin D1 (Yabut et al, 2010), a third 
possible effect of the overexpression of MNB/DYRK1A might be to modulate the cell cycle of 
neuronal progenitors. For instance, extended cell cycles have been found in a DS mouse model 
(Chakrabarti et al, 2007; Contestabile et al, 2007). This may be relevant since neurogenic 
progenitors have a longer cell cycle than proliferative progenitors, and lengthening cell-cycle 
could contribute to a switch from proliferative to neurogenic divisions (Calegary et al, 2005). 
Further work will be required to assess these hypotheses. 
 
Surprisingly, despite all the evidence pointing to various roles of MNB/DYRK1A in neural 
proliferation, neurogenesis and neuronal differentiation, no strong CNS developmental 
phenotypes have so far been described for most transgenic mice overexpressing Mnb/Dyrk1A. 
Nevertheless, all these transgenic mice exhibit learning/memory impairments (Smith et al, 1997; 
Altafaj et al, 2001; Branchi et al, 2004; Ahn et al, 2006). It is possible that moderate increases of 
MNB/DYRK1A could produce subtle phenotypes that would require a more detailed analysis to 
detect. However, we should not rule out the possibility that that due to the activities of 
MNB/DYRK1A in several sequential phases in proliferation/neurogenesis/differentiation, a 
maintained overexpression in the trangenic mice could result in compensatory phenotypes. 
Strikingly, the brains of 152F7 mice, which carry a YAC mouse line with three copies of at least 
two neighboring HSA21 genes in addition to MNB/DYRK1A, are enlarged (Smith et al, 1997; 
Branchi et al, 2004), a phenotype that apparently contradicts with the expected antiproliferative 
effect of MNB/DYRK1A (Yabut et al, 2010).  
 
It is also well known that cortical neurons of brains with DS exhibit dendritic shortening or 
atrophy (reviewed by Kaufman and Moser, 2000). Thus, another developmental process that 
could be impaired through the overexpression of MNB/DYRK1A in DS is dendritogenesis. 
Indeed, cultured cortical neurons of Mnb/Dyrk1A transgenic mice exhibit poorer dendrite 
arborization (Lepagnol-Bestel et al, 2009). Moreover, overexpression of MNB/DYRK1A in wild 
type primary mouse cortical neurons leads to similar changes (Lepagnol-Bestel et al, 2009), 
strongly suggesting that MNB/DYRK1A triploidy can impair dendrite development in DS. 
 
Increased cell death is also associated with DS. For instance, cultured human cortical DS neurons 
exhibit intracellular oxidative stress and increased apoptosis (Busciglio and Yankner, 1995). 
Furthermore, increased cell death has been observed in the forebrain of fetuses with DS (Guidi et 
al, 2008). The involvement of MNB/DYRK1A in the regulation of Caspase 9-mediated apoptosis 
in differentiating neurons of the developing retina has generated some speculation about the 
effects of MNB/DYRK1A gene-dosage imbalance in deregulating the apoptotic response in DS  
(Laguna et al, 2008). However, it seems unlikely that the overexpression of MNB/DYRK1A can 
contribute to the neuronal deficit of DS by stimulating developmentally regulated cell death 
since several studies have related increased MNB/DYRK1A levels to anti-apoptotic or cell 
survival effects rather than to the induction cell death (Chang et al, 2007; Laguna et al, 2008; 
Guo et al, 2010). As a matter of fact, we recently found that the overexpression of 
MNB/DYRK1A does not induce cell death during vertebrate CNS neurogenesis (Hammerle and 
Tejedor, unpublished results).  
 
 
CONCLUDING REMARKS AND PERSPECTIVES  
As already discussed, there is evidence accumulating regarding several key functions performed 
by MNB/DYRK1A in brain development. Now the major goal is to determine the underlying 
molecular mechanisms. This is going to be a complex task since there are clear indications that 
MNB/DYRK1A might act at the crossroads of several signaling pathways, probably helping to 
integrate various cellular processes (for example, proliferation and differentiation). Thus, we 
would like to propose some directions for future research that we think will provide insight into 
these relevant molecular mechanisms. 
 
As summarized in Table I, many proteins have been identified as possible substrates and/or  
interacting proteins of the MNB/DYRK1A kinase through very diverse approaches, and various 
signaling pathways have been associated with MNB/DYRK1A. Nevertheless, we know very 
little about the actual physiological substrates/interacting partners of MNB/DYRK1A in neuronal 
development. In large, this is due to the fact that most molecular studies have been carried out in 
non-neuronal cells. Thus, efforts should be made to address the true specificity of these putative 
MNB/DYRK1A related proteins in adequate neuronal systems and in suitable functional 
contexts. Also, given the wide molecular repertoire of substrates (transcription factors, 
translation factors, cytoskeletal proteins, membrane receptors, regulators of membrane dynamics, 
etc), it is possible that MNB/DYRK1A kinase could act at several levels in a multifaceted 
manner, integrating several cellular responses within a given neuronal process. For example, by 
acting on Cyclin D1 to stop the cell cycle as well as on NOTCH signaling to initiate 
differentiation, thereby co-ordinating the transition of neuronal precursors from proliferation to 
differentiation.  
 
In agreement with its capacity to phosphorylate such a wide repertoire of substrates, 
MNB/DYRK1A also displays a rather varied subcellular distribution during neurodevelopment 
(Hammerle et al, 2002, 2003b, 2008). Thus, the early literature classified MNB/DYRK1A as a 
nuclear protein kinase because it contained a bipartite nuclear translocation signal and 
MNB/DYRK1A-tagged peptides indeed localized in the nucleus of transfected cell lines (Becker 
et al, 2008). However, immunocytochemical analysis by high resolution confocal microscopy 
has since shown that the endogenous MNB/DYRK1A protein has a mainly cytoplasmic and 
perinuclear localization in differentiating mammalian neurons (Hammerle et al, 2008). 
Nevertheless, MNB/DYRK1A has also been detected in the form of speckles in neuronal nuclei 
at given developmental stages (Hammerle et al, 2003b; Hammerle et al, 2008). Thus, a working 
hypothesis is that MNB/DYRK1A is normally concentrated in the perinuclear area and that it 
translocates into the nucleus to regulate transcription factors in response to certain stimuli. It will 
therefore be very interesting to study the mechanisms that regulate this translocation process (see 
also the interesting comments about the distribution of MNB/DYRK1A in the adult mammalian 
brain in the accompanying review by Weigel et al, 2010).  
 
As previously discussed, there is also compelling evidence for the very precise spatio-temporal 
regulation of Mnb/Dyrk1A expression during brain development (Okui et al, 1999; Hammerle et 
al, 2002, 2003b, 2008), which appears to be crucial for MNB/DYRK1A function. For example, it 
has been reported that the transient expression/activation of MNB/DYRK1A induces neuronal 
differentiation (Yang et al, 2001; Kelly and Rahmani, 2005) but this is impaired by its stable 
over-expression (Park et al, 2007). Furthermore, it should be noted that the only well known 
mechanism to activate the MNB/DYRK1A kinase is through a transient Tyr-kinase activity that 
autophosphorylates tyrosine residues in the activation loop during protein translation (Lochhead, 
et al, 2005). This implies that the up-regulation of MNB/DYRK1A kinase can be indirectly 
controlled by regulating its expression, making the observed transient expression of 
MNB/DYRK1A in specific neurodevelopmental contexts (Fig. 1) even more relevant 
functionally. However, only a few molecules have been found to modulate Mnb/Dyrk1A gene 
expression in cell lines (reviewed by Becker and Sippl, 2010, see also Table I) and almost 
nothing is known about the mechanisms regulating its expression during brain development. 
Thus, studies in true neurodevelopmental systems will be required to dissect out the mechanisms 
that actually regulate Mnb/Dyrk1A expression and their implication in brain development.  
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Table I. Substrates and proteins that interact with MNB/DYRK1A in relation to its 
neuronal functions 
This is a list of proteins that possibly interact with or serve as substrates for the 
MNB/DYRK1A kinase. Since the spatio-temporal regulation of its expression appears 
to be critical to understand the MNB/DYRK1A’s roles in neuronal development, we 
have also included possible regulators of Mnb/Dyrk1A expression and of 
MNB/DYRK1A kinase activity. For each protein we show: its main molecular 
properties, the molecular relationship with MNB/DYRK1A, the experimental system 
used to define this relationship, the possible function in neuronal development (if any), 
and the literature showing the relationship to MNB/DYRK1A. This list has been 
restricted to those genes/proteins for which there is evidence in the literature of a 
neuronal related activity. Additionally, we highlight (*) those cases in which there is 
evidence (or strong indications) that the interaction with MNB/DYRK1A is involved in 
neuronal functions. 
Abbreviations. AD= Alzheimer Disease; Molecular relationship with MNB/DYRK1A: 
ActR = Regulator of Activity; ExpR= Regulator of Expression; I = Interacting protein; 
S= Substrate; ($) MNB/DYRK1A kinase primes the phosphorylation of several 
substrates by GSK3. Experimental system: CultNeu= Cultured neurons; ivCNS= CNS 
in vivo; NCL= Neural cell line; nNCL= non-Neural cell line. Functions: Dif= 
Differentiation; Other= Non developmental neuronal function; Prol= Proliferation; 
Syn= Synapse related; UF= Unknown  
 
Protein or  
Signalling  
pathway 
Molecular 
nature 
Molecular 
Relation with 
MNB/DYRK1A 
Experimental 
system 
Function  Literature 
Amphiphysin Protein associated with 
the cytoplasmic surface 
of synaptic vesicles 
S NCL, ivCNS Syn Murakami et al. 2006 
β-Amyloid Peptide derived from 
APP. Main component 
of amyloid plaques in 
AD 
ExpR ivCNS, NCL Other Kimura et al. 2007 
Arip4 (Androgen 
receptor interacting 
protein 4) 
Steroid hormone 
receptor cofactor 
I nNCL, 
CultNeu, 
ivCNS 
UF Sitz et al.  2004 
APP Amyloid precursor 
protein 
S nNCL Other Ryoo et al, 2008 
ASF (Alternative 
splicing factor) 
Splicing factor S, I NCL, nNCL Other Shi et al. 2008 
bFGF 
 
Growth factor ActR NCL Dif Yang et al. 2001 
* Caspase 9 Cystein aspartyl 
protease 
S nNCL, ivCNS Cell death Seifert et al. 2008, 
2009 Laguna et al 
2008 
* Cyclin D1 
 
Cell cycle regulator ? ivCNS, NCL Prol Yabut et al. 2010 
CREB (cAMP 
responsive element 
binding protein) 
Transcription factor S NCL Dif Yang et al. 2001 
CRY2 
(Chryptochrome2) 
Flavoprotein, involved 
in circadian rhythm 
S nNCL, ivCNS Other Kurabayashi et al. 
2010 
* DNM1 
(Dynamin1)  
Cytoplasmic protein, 
involved in membrane 
trafficking 
S nNCL, ivCNS Dif Chen-Hwang et al. 
2002;  Huang et al. 
2004; Hämmerle et al. 
2003b; Hämmerle et 
al. 2008 
Endophilin 1 Cytoplasmic protein 
involved in membrane 
trafficking 
I ivCNS Syn Murakami et al. 2009 
E2F1 Transcription factor, 
involved in  cell cycle 
regulation 
ExpR NCL, nNCL Prol, Dif Maenz et al. 2008 
FKHR (Forkhead in 
rhabdoyosarcoma,) 
Transcription factor S, I nNCL UF Woods et al. 2001b; v 
Groote-Bidlingmaier et 
al. 2003 
GLI1 (Glioma –
associated oncogene 
1) 
Transcription factor 
involved in SHH 
signaling 
S NCL, nNCL Prol/Dif  Mao et al. 2002 
Morita et al. 2006 
* GSK-3 (Glycogen 
Synthase Kinase 3) 
Protein kinase involved  
in multiple cellular 
processes 
$ nNCL, 
CultNeu, 
ivCNS 
Dif, other Woods et al. 2001a; 
Skurrat and Dietrich, 
2004, Morita et al. 
2006 ; Scales et al, 
2009 
Hip1 (Huntingtin 
interacting protein1) 
Accessory protein of 
the clathrin-mediated 
endocytosis pathway 
S NCL Dif Kang et al. 2005 
INI1//SNF5; SNR1 Chromatin modifying 
proteins 
I NCL, 
CultNeu, 
ivCNS 
Prol Kinstrie et al., 2006; 
Lepagnol-Bestel et al, 
2009 
* MAP1B Microtulbule 
associated protein 
S nNCL, 
CultNeu 
Dif Scales et al, 2009 
NFAT (Nuclear 
factor of activated T-
cells)  
Transcription factor S ivCNS, NCL Dif Arron et al. 2006; 
Gwack et al. 2006 
* Notch  Cell-cell signalling 
transmembrane 
receptor protein 
S NCL, nNCL,  
ivCNS 
Prol, Dif Fernández-Martínez et 
al. 2009;  
NRSF/REST 
(neuron-restrictive 
silence factor) 
Transcriptional 
repressor 
ExpR nNCL, ivCNS Prol/Dif Canzonetta et al. 2008 
PAHX-AP1 Phytanoyl-CoA α- 
hydroxylase associated 
protein 1, brain specific 
protein 
I NCL UF Bescond and Rahmani, 
2005 
Presenilin1 catalytic subunit  
of γ-secretase 
S NCL, nNCL, 
ivCNS 
UF Ryu et a. 2010 
Ras/ Map Kinase 
signaling 
Transmemenbrane 
signaling pathway 
I NCL Dif Kelly and Rahmani 
2005 
* SEPT4 (Septin4) GTPases and 
cytosketal scafolding 
protein 
 
S nNCL, ivCNS Syn Sitz et al. 2008 
SIRT1 NAD_-dependent 
protein deacetylase 
 
S nNCL Cell death Guo et al. 2010 
* SPRY2 (Sprouty 2) negative modulator of 
growth factor-mediated 
MAPK signaling 
S CultNeu,  
ivCNS 
Prol, Dif Aranda et al, 2008 
STAT3    Signal transducer and 
activator of 
transcription  
S nNCL UF Matsuo et al. 2001; 
Wiechmann et al. 2003 
SJ1 (synaptojanin1) phosphoinositide 
phosphatase 
S ivCNS Syn Adajev et al. 2006 
α-synuclein Cytoplasmic proteín, 
major component of 
Lewy bodies 
S NCL, ivCNS Other Kim et al. 2006 
* TAU  Cytoskeletal protein, 
microtubule associated  
S nNCL, ivCNS Other  Woods et al. 2001a; 
Kimura et al.2007; 
Ryoo et al, 2007 
14-3-3 14-3-3 family of 
regulating proteins 
I, ActR NCL, nNCL UF Kim et al, 2004 Alvarez 
et al 2007 
 
FIGURE LEGENDS 
 
Fig. 1. Schematic representation of the sequential expression of Mnb/Dyrk1A during the 
transition from neural proliferation to neuronal differentiation.  
In the vertebrate neuroepithelia, Mnb/Dyrk1A mRNA is first transiently expressed in 
preneurogenic progenitors, before it is asymmetrically segregated during cell division and it is 
inherited by only one of the daughter progenitor cells, triggering the onset of neurogenic 
divisions. Its expression is maintained in neurogenic progenitors although at a lower level. Later, 
Mnb/Dyrk1A is also transiently upregulated in postmitotic precursors (newborn neurons) and 
downregulated as the neuron begins to migrate away form the ventricular zone (VZ). Once the 
migrating neuron reaches its target position, Mnb/Dyrk1A is again expressed and it translocates 
transiently into the nucleus preceding the onset of dendrite formation. As dendrites begin to 
grow, MNB/DYRK1A localizes to the apical side of the growing dendrites. 
 
Fig. 2. A working model for the involvement of MNB/DYRK1A overexpression in the 
neuronal deficit of Down syndrome. 
Schematic representation of the pattern of progenitor division and neuronal generation in a 
normal brain, and the possible consequences that MNB/DYRK1A overexpression might cause 
during neurogenesis in the DS brain. During normal neurogenesis, the transient expression of 
Mnb/Dyrk1A in preneurogenic progenitors triggers the onset of neurogenic divisions and 
consequently, the production of neurons. The increase in the level of Mnb/Dyrk1A expression in 
DS may produce the precocious onset of neurogenic progenitors and a concomitant loss of 
proliferating progenitors, leading to a reduction in the total number of neurogenic lineages. 
Additionally, the overexpression of MNB/DYRK1A might induce premature cell cycle arrest of 
neurogenic progenitors leading to a decrease in the number of neurogenic divisions undertaken 
by each neurogenic progenitor. Thus, the consequences of these alterations in neurogenesis 
would be a decrease in the production of neurons. 
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